imatinib mesylate has been researched along with Cognition Disorders in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bisson, CM; Boehm, GW; Chumley, MJ; Eimerbrink, MJ; Kranjac, D; Nouri, JN; Vinson, BT; Weintraub, MK | 1 |
1 other study(ies) available for imatinib mesylate and Cognition Disorders
Article | Year |
---|---|
Imatinib methanesulfonate reduces hippocampal amyloid-β and restores cognitive function following repeated endotoxin exposure.
Topics: Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Benzamides; Cognition Disorders; Disease Models, Animal; Down-Regulation; Endotoxins; Hippocampus; Humans; Imatinib Mesylate; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Piperazines; Pyrimidines | 2013 |